PulteGroup heads into its Tuesday earnings release with options traders paying for protection at levels not seen in the past three months. Put buyers have pushed the ratio above 1.16 — nearly 1.6 standard deviations above its 20-day average. That's as defensive as positioning has been all year. The stock closed Friday at $127.56, up 8% for the month but down 2.4% on the day.
Short interest has climbed three sessions in a row and is up 3.7% over the past week to 3.7% of free float. Borrow costs edged higher into the print, though utilisation has eased from March highs. The setup is tense but not extreme — nothing like the 9.3% utilisation peak hit earlier in the year. Availability remains ample. Still, the combination of fresh shorts and suddenly heavy put demand suggests nervous money is hedging ahead of the results.
Three major firms lifted price targets within the past week. UBS moved to $162 on Thursday, Wells Fargo to $140, and Evercore ISI to $151. All maintained buy-equivalent ratings. The message was consistent: demand holding up better than feared, margin outlook intact. But the recent upgrades sit uncomfortably beside April's sharp pullback in targets. BofA trimmed from $145 to $140 on April 20. Truist cut from $170 to $150 on April 16. Most dramatic was Seaport Global, which slashed from $155 to $100 and downgraded to Sell on April 7. The firm cited an expected 9% year-over-year order decline for the second half and deteriorating affordability. Bulls counter that the active-adult segment — roughly 20% of revenue — is set to normalise back toward 25%, supporting gross margins. The disagreement is less about whether housing demand is slowing and more about whether PulteGroup can sustain pricing power through the cycle.
Insider activity has been one-way. Net sales reached $43 million over the past 90 days, led by CEO Ryan Marshall's $14.9 million transaction in early February. There were no offsetting purchases. T. Rowe Price added 2.4 million shares in the first quarter, now holding 2.2% of the company. Institutional positioning otherwise looks stable. Factor scores are middling — EPS momentum sits in the 24th percentile over 30 days, though the company ranks in the 62nd percentile for earnings surprise. Valuation multiples have compressed: the P/E ratio climbed to 12.3x as the stock lagged estimates, while price-to-book hit 1.73x.
The report will test whether order trends stabilised in March or continued the weakness flagged by the bears. Regional divergence matters — Florida strength versus pressure in the West and Texas. The stock has historically drifted lower after prints, falling roughly 4% in the five days following the last three events. Peers are mixed: DHI rose 6.7% over the past week, TMHC up 4.3%, while TOL and CCS both slipped. Options positioning says the market is bracing for disappointment.
See the live data behind this article on ORTEX.
Open PHM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
